19 June 2020: The MRCA Treatment Pathway 1 and Treatment Pathway 2 information below has been retained for historical purposes only. A Single Treatment Pathway has been in effect since 12 December 2019. See section 8.1 Overview for current information.

Last amended: 20 September 2012

Unless a person is entitled to a Gold Repatriation Health Card, MRCA delegates are required to decide which Treatment P — athway is most appropriate following an assessment of a person's needs pursuant to section 325 of the MRCA.

Upon acceptance of liability or when a person claims compensation, a delegate must carry out a needs assessment under section 325 of the MRCA, and then determine, under section 327, whether the claimant should have their treatment costs reimbursed and be issued with a Treatment Authority letter setting out a specified authority for treatment of the accepted conditions (Treatment Pathway 1) or whether they should be issued with a White Repatriation Health Card (Treatment Pathway 2).

In accordance with section 345 of the MRCA a decision under section 327, about which treatment path applies, is not an original determination and therefore not a reviewable decision for the purposes of Chapter 8 of the MRCA.  However the decision on the appropriate treatment pathway may be changed following a subsequent needs assessment as per paragraph 8.2.1 below.

This section contains the following topics:

19 June 2020: The MRCA Treatment Pathway 1 and Treatment Pathway 2 information below has been retained for historical purposes only. A Single Treatment Pathway has been in effect since 12 December 2019. See section 8.1 Overview for current information.

Last amended: 20 September 2012

Unless a person is entitled to a Gold Repatriation Health Card, MRCA delegates are required to decide which Treatment P — athway is most appropriate following an assessment of a person's needs pursuant to section 325 of the MRCA.

Upon acceptance of liability or when a person claims compensation, a delegate must carry out a needs assessment under section 325 of the MRCA, and then determine, under section 327, whether the claimant should have their treatment costs reimbursed and be issued with a Treatment Authority letter setting out a specified authority for treatment of the accepted conditions (Treatment Pathway 1) or whether they should be issued with a White Repatriation Health Card (Treatment Pathway 2).

In accordance with section 345 of the MRCA a decision under section 327, about which treatment path applies, is not an original determination and therefore not a reviewable decision for the purposes of Chapter 8 of the MRCA.  However the decision on the appropriate treatment pathway may be changed following a subsequent needs assessment as per paragraph 8.2.1 below.

This section contains the following topics: